Pyridine

Pyridine

SCHEMBL950273

CC(=O)Nc1ccc2cc(S(=O)(=O)O)ccc2c1.c1ccncc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 2/20 0.54
CASP6 P55212 1/20 0.51
GAA P10253 2/20 0.48
HPGD P15428 2/20 0.48
KDM4E B2RXH2 4/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 4/20 0.47
GLA P06280 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
TNNI3 P19429 1/20 0.47
TNNT2 P45379 1/20 0.47
TNNC1 P63316 1/20 0.47
RUNX1 Q01196 1/20 0.47
CBFB Q13951 1/20 0.47
POLB P06746 2/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950400 0.89 SNCA (0.59) SNCACASP6KDM4EMEN1KMT2A
SCHEMBL8784484 0.87 SNCA (0.58) SNCACASP6KDM4EMEN1KMT2A
Water SCHEMBL11035834 0.87 SNCA (0.58) SNCACASP6KDM4EMEN1KMT2A
SCHEMBL6079123 0.84 CASP6 (0.56) SNCACASP6KDM4EMEN1KMT2A
SCHEMBL6079107 0.83 CASP6 (0.55) SNCACASP6KDM4EMEN1KMT2A
Pyridine SCHEMBL344354 0.80 ENPP2 (0.52) GAAHPGDKDM4EMEN1KMT2A
Pyridine SCHEMBL6114696 0.79 SNCA (0.57) SNCAGAAMAPTLMNASMN1; SMN2
Pyridine SCHEMBL8669427 0.79 GAA (0.57) GAAHPGDKDM4EMEN1KMT2A
Pyridine SCHEMBL6193686 0.78 ALDH1A1 (0.61) GAAHPGDKDM4EMEN1KMT2A
Pyridine SCHEMBL5891724 0.78 CASP6 (0.51) CASP6GAAHPGDKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20070004736-A1 Imidazole derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-04 US disclosed
EP-1564213-A1 IMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2005-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004736-A1 Imidazole derivative, process for producing the same, and use HRH4, F2, HRH2 SNCA 3053/4885CASP6 3275/4885GAA 4808/4885
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE F2, H1-3, CYC1 SNCA 3232/4885CASP6 3326/4885GAA 4834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.